JA
AMPH icon

JOYN Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

JOYN Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-137
Closed -$3K – 178
2018
Q4 		$3K Buy
137
+31
+29% +$611 ﹤0.01% 1366
2018
Q3 		$2K Buy
106
+49
+86% +$873 ﹤0.01% 1423
2018
Q2 		$1K Buy
+57
New +$996 ﹤0.01% 1515

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JOYN Advisors's AMPH Position: Q1 2019 in Review

JOYN Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2019, closing a stake of 137 shares — an estimated $3K sold.

JOYN Advisors first reported a position in AMPH in Q2 2018 and held it in 3 quarters. The position peaked at $3K in Q4 2018. 135 funds tracked by Wall St. Rank hold AMPH as of Q1 2019.

  • JOYN Advisors reported no remaining Amphastar Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • JOYN Advisors sold 137 Amphastar Pharmaceuticals shares in Q1 2019, an estimated $3K.
  • JOYN Advisors first reported a position in Amphastar Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • JOYN Advisors's Amphastar Pharmaceuticals position peaked at $3K in Q4 2018.
  • 135 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.